Anti-inflammatory activity of chondroitin sulphate: New functions from an old natural macromolecule

Inflammopharmacology

Volumn 19, Issue 6, 2011, Pages 299-306

  Volpi, Nicola ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Adjuvant arthritis; Anti inflammatory drug; Chondroitin sulphate; Glycosaminoglycans; Oral route; Osteoarthritis

Indexed keywords

C REACTIVE PROTEIN; CHONDROITIN SULFATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; KERATAN SULFATE;

ADJUVANT ARTHRITIS; ANTIINFLAMMATORY ACTIVITY; ARTICULAR CARTILAGE; CARTILAGE INJURY; CHONDROPROTECTION; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE COURSE; DISEASE MARKER; DOSE RESPONSE; DRUG EFFICACY; EXPERIMENTAL MODEL; EXPERIMENTAL STUDY; HUMAN; IN VITRO STUDY; INFLAMMATION; MACROMOLECULE; NONHUMAN; OSTEOARTHRITIS; PAW EDEMA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; REVIEW; RHEUMATOID ARTHRITIS; STRUCTURE ACTIVITY RELATION; SYNOVITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CHONDROITIN SULFATES; CLINICAL TRIALS AS TOPIC; HUMANS; INFLAMMATION; META-ANALYSIS AS TOPIC; OSTEOARTHRITIS;

EID: 84355161625     PISSN: 09254692     EISSN: 15685608     Source Type: Journal    
DOI: 10.1007/s10787-011-0098-0     Document Type: Review

References (36)

1. Bauerova K, Ponist S, Kuncirova V, Mihalova D, Paulovicova E, Volpi N (2011) Protective effect of chondroitin sulfate on induced arthritis in rats. Osteoarthr Cartil 19:1373-1379
2. A Bendele J McComb T Gould T McAbee G Sennello E Chlipala M Guy 1999 Animal models of arthritis: relevance to human disease Toxicol Pathol 27 134 142 10367688 10.1177/019262339902700125 1:STN:280:DyaK1M3psVWjug%3D%3D (Pubitemid 29075759)
3. GR Burmester B Stuhlmuller G Keyszer RW Kinne 1997 Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis? Arthritis Rheum 40 5 18 9008595 10.1002/art.1780400104 1:STN:280:DyaK2s7mtFegug%3D%3D (Pubitemid 27044031)
4. GM Campo A Avenoso S Campo A D'Ascola P Traina D Samà A Calatroni 2008 Purified human plasma glycosaminoglycans reduced NF-kappaB activation, pro-inflammatory cytokine production and apoptosis in LPS-treated chondrocytes Innate Immun 14 233 246 18669609 10.1177/1753425908094725 1:CAS:528: DC%2BD1cXhtVKnurzF
5. GM Campo A Avenoso S Campo P Traina A D'Ascola A Calatroni 2009 Glycosaminoglycans reduced inflammatory response by modulating toll-like receptor-4 in LPS-stimulated chondrocytes Arch Biochem Biophys 491 7 15 19800307 10.1016/j.abb.2009.09.017 1:CAS:528:DC%2BD1MXhtlGhsLzF
6. N Cañas R Gorina AM Planas J Vergés E Montell AG García MG López 2010 Chondroitin sulfate inhibits lipopolysaccharide-induced inflammation in rat astrocytes by preventing nuclear factor kappa B activation Neuroscience 167 872 879 20206237 10.1016/j. neuroscience.2010.02.069
7. SY Cho JS Sim CS Jeong SY Chang DW Choi T Toida YS Kim 2004 Effects of low molecular weight chondroitin sulfate on type II collagen-induced arthritis in DBA/1J mice Biol Pharm Bull 27 47 51 14709897 10.1248/bpb.27.47 1:CAS:528:DC%2BD2cXhsVCisrY%3D (Pubitemid 41656671)
8. ZL Chu TA McKinsey L Liu JJ Gentry MH Malim DW Ballard 1997 Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control Proc Natl Acad Sci USA 94 10057 10062 9294162 10.1073/pnas.94.19.10057 1:CAS:528:DyaK2sXmt1Cquro%3D (Pubitemid 27406993)
9. I Cinel SM Opal 2009 Molecular biology of inflammation and sepsis: a primer Crit Care Med 37 291 304 19050640 10.1097/CCM.0b013e31819267fb 1:CAS:528:DC%2BD1cXhsFCnu7jE
10. J Egea AG García J Verges E Montell MG López 2010 Antioxidant, antiinflammatory and neuroprotective actions of chondroitin sulfate and proteoglycans Osteoarthr Cartil 18 Suppl 1 S24 S27 20399898 10.1016/j.joca.2010.01.016
11. S Ghosh MS Hayden 2008 New regulators of NF-kappaB in inflammation Nat Rev Immunol 8 837 848 18927578 10.1038/nri2423 1:CAS:528:DC%2BD1cXht12isLfN
12. G Herrero-Beaumont ME Marcos O Sánchez-Pernaute R Granados L Ortega E Montell J Vergés J Egido R Largo 2008 Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritis Br J Pharmacol 154 843 851 18536737 10.1038/bjp.2008.113 1:CAS:528: DC%2BD1cXmvFWju7k%3D (Pubitemid 351821578)
13. EO Iwalewa LJ McGaw V Naidoo JN Eloff 2007 Inflammation: the foundation of disease and disorders. A review of phytomedicines of South African origin used to treat pain and inflammatory conditions Afr J Biotech 6 2868 2885 1:CAS:528:DC%2BD1cXis1Gmtrg%3D
14. C-H Jin U Yang S-H Kim J-W Ryu J-C Lee D-S Lee T-H Lee 2007 The protective effect of chondroitin from Raja kenojei cartilage on collagen-induced arthritis in DBA/1 J Mice Food Sci Biotechnol 16 594 599 1:CAS:528: DC%2BD2sXhtFanu7nL
15. C Jomphe M Gabriac TM Hale L Héroux LE Trudeau D Deblois E Montell J Vergés P du Souich 2008 Chondroitin sulfate inhibits the nuclear translocation of nuclear factor-kappaB in interleukin-1beta-stimulated chondrocytes Basic Clin Pharmacol Toxicol 102 59 65 17983423 1:CAS:528:DC%2BD1cXhs1CqtLs%3D (Pubitemid 350301907)
16. KM Jordan NK Arden M Doherty B Bannwarth JW Bijlsma P Dieppe, et al. 2003 EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) Ann Rheum Dis 62 1145 1155 14644851 10.1136/ard.2003.011742 1:STN:280: DC%2BD3srpsFGmug%3D%3D (Pubitemid 37500619)
17. A Kahan D Uebelhart F De Vathaire PD Delmas JY Reginster 2009 Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial Arthritis Rheum 60 524 533 19180484 10.1002/art.24255 1:CAS:528:DC%2BD1MXjt1Cnsr4%3D
18. K Kannan RA Ortmann D Kimpel 2005 Animal models of rheumatoid arthritis and their relevance to human disease Pathophysiology 12 167 181 16171986 10.1016/j.pathophys.2005.07.011 (Pubitemid 41375640)
19. M Karin A Lin 2002 NF-kappaB at the crossroads of life and death Nat Immunol 3 221 227 11875461 10.1038/ni0302-221 1:CAS:528:DC%2BD38XitVWlt7g%3D (Pubitemid 34213423)
20. Kingston AE, Carney SL, Hicks CA, Billingham MEJ (1993) Arthritis and Osteoarthritis. Birkhauser, Basel, pp 75-79
21. T Omata Y Itokazu N Inoue Y Segawa 2000 Effects of chondroitin sulfate-C on articular cartilage destruction in murine collagen-induced arthritis Arzneimittelforschung 50 148 153 10719618 1:CAS:528:DC%2BD3cXitFequrw%3D (Pubitemid 30114844)
22. JY Reginster F Heraud B Zegels O Bruyere 2007 Symptom and structure modifying properties of chondroitin sulfate in osteoarthritis Mini Rev Med Chem 7 1051 1061 17979808 10.2174/138955707782110088 1:CAS:528:DC%2BD2sXht1Sjs7fI (Pubitemid 47554774)
23. F Ronca L Palmieri P Panicucci G Ronca 1998 Anti-inflammatory activity of chondroitin sulfate Osteoarthr Cartil 6 Suppl A 14 21 9743814 10.1016/S1063-4584(98)80006-X (Pubitemid 28255099)
24. Z Shriver S Raguram R Sasisekharan 2004 Glycomics: a pathway to a class of new and improved therapeutics Nat Rev Drug Discov 3 863 873 15459677 10.1038/nrd1521 1:CAS:528:DC%2BD2cXotVSmtbs%3D (Pubitemid 39405947)
25. MJ Stables DW Gilroy 2011 Old and new generation lipid mediators in acute inflammation and resolution Progr Lipid Res 50 35 51 10.1016/j.plipres.2010.07. 005 1:CAS:528:DC%2BC3cXhs1WktL7P
26. K Sugahara T Mikami T Uyama S Mizuguchi K Nomura H Kitagawa 2003 Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate Curr Opin Struct Biol 13 612 620 14568617 10.1016/j.sbi.2003.09.011 1:CAS:528:DC%2BD3sXot12ht70%3D (Pubitemid 37244117)
27. D Uebelhart 2008 Clinical review of chondroitin sulfate in osteoarthritis Osteoarthr Cartil 16 S19 S21 18674931 10.1016/j.joca.2008.06.006
28. D Uebelhart EJ Thonar J Zhang JM Williams 1998 Protective effect of exogenous chondroitin 4,6-sulfate in the acute degradation of articular cartilage in the rabbit Osteoarthr Cartil 6 Suppl A 6 13 9743813 10.1016/S1063-4584(98)80005-8 (Pubitemid 28255098)
29. M Vallières P du Souich 2010 Modulation of inflammation by chondroitin sulfate Osteoarthr Cartil 18 Suppl 1 S1 S6 20399900 10.1016/j.joca.2010.02.017
30. ESO Vanderlei KKNR Patoilo NA Lima APS Lima JAG Rodrigues LMCM Silva MEP Lima V Lima NMB Benevides 2010 Antinociceptive and anti-inflammatory activities of lectin from the marine green alga Caulerpa cupressoides Int Immunopharmacol 10 1113 1118 20601179 10.1016/j.intimp.2010.06.014 1:CAS:528:DC%2BC3cXhtVKjtrrP
31. N Volpi 2007 Analytical aspects of pharmaceutical grade chondroitin sulfates J Pharm Sci 96 3168 3180 17630645 10.1002/jps.20997 1:CAS:528:DC%2BD2sXhsVers7jL
32. N Volpi 2009 Quality of different chondroitin sulfate preparations in relation to their therapeutic activity Pharm Pharmacol 61 1271 1280 1:CAS:528:DC%2BD1MXhtlWrurzF
33. N Volpi 2010 Dermatan sulfate: recent structural and activity data Carb Polymers 82 233 239 10.1016/j.carbpol.2010.05.009 1:CAS:528:DC%2BC3cXptValsrs%3D
34. S Yamada K Sugahara 2008 Potential therapeutic application of chondroitin sulfate/dermatan sulfate Curr Drug Discov Technol 5 289 301 19075609 10.2174/157016308786733564 1:CAS:528:DC%2BD1MXmt1egsA%3D%3D
35. W Zhang M Doherty BF Leeb L Alekseeva NK Arden JW Bijlsma, et al. 2007 EULAR evidence based recommendations for the management of hand osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) Ann Rheum Dis 66 377 388 17046965 10.1136/ard.2006.062091 1:CAS:528:DC%2BD2sXjvFSht78%3D (Pubitemid 46579641)
36. J Zhong JM Kyriakis 2007 Dissection of a signaling pathway by which pathogen-associated molecular patterns recruit the JNK and p38 MAPKs and trigger cytokine release J Biol Chem 282 24246 24254 17584736 10.1074/jbc.M703422200 1:CAS:528:DC%2BD2sXoslOnuro%3D (Pubitemid 47328061)